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Abstract
The intelligence quotient (IQ) of 60 patients with homozygous sickle cell (SS) disease and 60 age and sex matched controls with a normal haemoglobin (AA) genotype aged 15-18 years, followed up in a cohort study from birth, was assessed by the Wechsler intelligence scales for children or for adults. IQ appeared to be normally distributed in both genotypes but mean values in SS disease were 5 6 points (95% confidence interval (CI) 1.0 to 10.2) lower than in AA controls (p=0-016). The difference occurred in both verbal (5.5 points, p=0.017) and performance (5.0 points, p=0.044) subscales of the IQ score and the IQ defect in SS disease was associated with a significantly lower attention factor score (p=0.005) but not with other factor scores. The genotype difference in IQ was not accounted for by differences in parental occupational level, school absenteeism, or school drop out, or reported activity level. In SS disease, IQ was not related to mean steady state haemoglobin, fetal haemoglobin, or mean cell haemoglobin concentration, or clinical severity as judged by the frequency of painful crises, hospital admission, or sick visits. IQ, at age 15-18 years, correlated with the patients' height at all ages from 1 to 10 years (partial correlations increasing from 0-14 (p=0.15) at age 1 to 0-27 (p=0 004) at age 10). Adjusting for height reduced the mean genotype difference in IQ to 5*5 (95% CI 0*6 to 10.3) points at age 1 and to 2-6 points (95% CI to -2-3, 7.5) at age 10. Prepubertal height therefore accounted for much of the genotype difference in IQ. It is speculated that early factors, possibly nutritional, contribute to Other possibilities include impaired neurodevelopment or subclinical brain damage as evidenced by the recent more sensitive imaging procedures such as magnetic resonance.5 6 In the Jamaican cohort study, a representative sample of patients with SS disease and age and sex matched controls with a normal haemoglobin (AA) genotype have been followed up from birth with regular assessments of clinical features, haematology, and social indices. We have compared the intelligence quotient (IQ) measured by psychometric testing in patients and controls when aged 15-18 years, and assessed the relative contributions of clinical, haematological, and social factors to the genotype difference.
Patients and methods
Subjects attended the sickle cell clinic of the University Hospital of the West Indies and participated in a cohort study identified by the neonatal screening of 100 000 consecutive normal deliveries at the main government maternity (Victoria Jubilee) hospital.7 The first 125 babies with an SS phenotype, born between June 1973 and January 1976, were each matched with two normal (AA) controls of the same sex, born closest in time to the index case giving a total group of 250 AA controls. Of the 125 subjects with an SS phenotype, 18 were found to have other genotypes such as sickle cell P3 thalassaemia or sickle cell hereditary persistence of fetal haemoglobin, leaving 107 subjects with an SS genotype. By the study date (January 1991-January 1992), 29 had died and seven emigrated leaving a group of 71 SS patients who were aged 15-18 years. Of these, 11 patients were not available (seven lived distant from Kingston, two defaulted, and two were consistently unwell at clinic visits during the study period) and IQ was assessed in the remaining 60 SS patients (30 male, 30 female). Of the two AA controls originally selected for each of these 60 patients, a single control remained available for 26 cohorts, neither control in five, and both controls in 29. For the latter group, the first of the two controls attending the clinic for routine assessment was interviewed, and for the five without controls, the unused sex matched control of an adjacent patient with birth date within three months of the index case was taken. All subjects were interviewed at the sickle cell unit and were clinically well at the time of assessment.
INTELLIGENCE TESTS
The Wechsler intelligence scale for childrenrevised (WISC-R),8 designed for subjects under 17 years, was given to 38 such subjects and inadvertently to nine subjects over this age. The Wechsler adult intelligence scalerevised (WAIS-R),9 designed for subjects 16 years and above, was given to 73 subjects.
Subjects aged 16-17 years were given either test depending on availability (17 received WISC-R and 25 WAIS-R). Performance on the two tests has been reported to be highly correlated (r=0.88)9 but as this does not imply close agreement, the possible influence of test type on genotype differences was assessed in the analysis. The wording of test items and directions were modified for local conditions and the vocabulary and picture arrangement subtests omitted in accordance with previous studies of the WISC-R in Jamaica.10 Subtest scores were prorated as directed in the respective manuals, and factorised according to the method of Bannatyne.ll
SOCIAL FACTORS
The number of social, physical, and intellectual activities engaged in and the degree of participation, was assessed by the activity subscale of the social competence scale in the child behavior checklist (self report form) and depicted as T scores according to the manual.12 Days absent from school during the period September-May before the study were obtained from classroom registers for 17 pairs where both patient and control were still at school.
Socioeconomic status was determined from (i) the occupation of main guardian (termed 'parental') ranked in three categories (skilled, semiskilled, unskilled) on a scale developed for Jamaica13; (ii) indices of overcrowding (persons per room); (iii) sanitation (toilet type and location); and (iv) availability of electricity and water. Socioeconomic status14 was scored by structured interview in all subjects (except one AA control who emigrated during the study).
CLINICAL SEVERITY
Clinical severity of SS disease was assessed by the number of hospital admissions, sick clinic visits, and painful crises from birth to the date of IQ assessment. It is recognised that the first two events may be influenced by arbitrary factors but the combination of indices was considered a better indication of overall clinical severity than any single index. Morbidity data were believed to be complete as the sickle cell clinic was the primary, and generally the only, source of health care, and events occurring between clinic visits were recalled at each attendance. HAEMATOLOGY Haematological indices were measured in a Coulter S plus IV (Coulter Electronics, Hialeah, Florida) and the mean cell haemoglobin concentration (MCHC) calculated from the spun microhaematocrit. Fetal haemoglobin was measured by alkali denaturation.15 The number of a globin genes was determined by standard DNA technology using restriction endonuclease analysis of DNA obtained from peripheral blood. Average steady state values after the age of 5 years were used for assessing the influence of haematological indices on IQ.
Serum iron and iron binding capacity were measured by the method of Beale et al annually but the analysis was confined to values at the second (serum iron 36 AA, 47 SS; transferrin saturation 32 AA, 46 SS) and eighth birthdays (serum iron 40 AA, 49 SS; saturation 38 AA, 48 SS).16 GROWTH AND DEVELOPMENT Birth weight and head circumference were measured as described17 and height and weight at three month intervals coinciding with birthday visits using standard protocols.18 To avoid potential bias from exclusion of cases without appropriate height data near to their birthday, standard deviation (z) scores were calculated for both genotypes from the nearest height to each age from 1 to 10 years using height standards previously derived from SS patients in the cohort study. Skinfold thickness at biceps, triceps, subscapular, and suprailiac sites were measured using skinfold calipers (Holtain Instruments Ltd, Crymmych) and standard protocols and data are presented as the sum of all four skinfolds at age 8 years (±3 months).
The relationship of adolescent growth to IQ in both genotypes was assessed using a mathematical model (Preece-Baines model 1),19
which describes the timing of the adolescent growth spurt in each individual. Height data, at six month intervals (±2 months) from the age of 1 year, were fitted to this model by computer using the method of least squares.
The ages at growth spurt 'take off' and peak height velocity, derived from this model were available for all except one AA subject and were used for analysis.
ANALYSIS
Distributions that were markedly skewed (fetal haemoglobin, serum iron, transferrin saturation, weight, and sum of skinfolds) were normalised using a loge transformation before analysis. Since SS and AA matched pairs were not always given the same IQ test; unmatched methods of analysis were used. The mean genotype difference in IQ scores with the WAIS-R test was not statistically different from that with the WISC-R test (p=0 13), and were therefore assumed to be the same for each test type. With the WAIS-R test, average values were 11-9 points (95% confidence interval (CI) 7-2 to 16.6) higher than with the WISC-R test, so test type was controlled for in all analyses. The mean IQ in the two genotypes, taking test type into account, were compared using analysis of variance, and adjusting for covariates by multiple regression. The regression line of IQ on each covariate was assumed to be parallel in both genotypes (homogeneity of regression) unless there was evidence to the contrary. The matching variables, age and sex were included in multivariable analyses except when shown not to be important. Homogeneity of variance was tested using O'Brien's method.20 A study of this size is able to detect a 7-8 point real difference in IQ between the genotypes with a power of 80%, assuming an IQ standard deviation of 15 points and a significance level of 5%. Adjusting for parental occupation, school attendance, activity level, or domestic environment made little difference to the mean genotype difference in IQ.
Results

CLINICAL SEVERITY
Among SS patients, the median number (range) of clinical severity related events was 2 (0-18) hospital admissions, 24 (1-81) sick visits, and 2 (0-28) painful crises. After adjustment for test type, there were no significant correlations between IQ and clinical severity (partial correlations for hospital admissions =-0-16, p=0-22; sick visits =0-06, p=0-63; painful crises =-0-04, p=0 74).
HAEMATOLOGY
As expected, there were highly significant genotype differences in steady state total haemoglobin, fetal haemoglobin, and MCHC but not in indices of iron status at ages 2 or 8 years (table 3) . Within SS subjects, the haemoglobin and fetal haemoglobin concentrations, and MCHC were not related to IQ. a Thalassaemia status (mean IQ in 14 subjects heterozygous for ot+ thalassaemia was 1-2 (-6-0 to 8 5) points lower than in 44 subjects with a normal ao globin gene complement) was also not related to IQ. Adjustment for serum iron concentration and transferrin saturation at ages 2 and 8 years did not change the mean genotype IQ difference.
GROWTH AND DEVELOPMENT
Mean weights at birth and at 2 years were similar in AA and SS subjects, although weight None ofthe studied social factors appeared to account for this difference. Greater school absenteeism has been reported in SS disease3 23 but did not occur in this study possibly due to the lack of school attendance data at earlier ages or the small sample size. Neither were there any genotype differences in the number or degree of reported social, physical and intellectual activities, parental occupation, density of persons per room, or other social factors. SS subjects were therefore similar to controls in these social and economic indices and adjusting for these variables did not affect the genotype difference in IQ. Neither was there any evidence that IQ within SS disease was related to clinical severity as noted in other studies,' 24 or to haematological indices including iron status.
The relation of growth and IQ produced the most interesting results. No genotype difference occurred in weight at birth, 2 years, or 8 years (after adjusting for height). On the other hand, height was significantly lower in SS disease at all ages from 2 through 10 years and adjusting the genotype difference in IQ for height progressively reduced this difference with increasing age. These observations suggest that a factor common to both growth and mental development may be responsible for these findings.
Early nutrition, especially chronic undernutrition is one such factor in normal children. [25] [26] [27] The type of cognitive deficit found in the SS children with a mild, generalised lowering of IQ with associated attentional deficits, resembles that seen in chronically undernourished children.28 The generalised deficit in height, weight and skinfolds, the delayed growth spurt and lower growth velocity, and the delay in sexual maturation seen in SS disease closely resemble the growth and development in chronically malnourished children.29 The greater metabolic rate in SS children3>32 may also contribute as this predicts greater energy requirements,33 and the role of suboptimal nutrition in SS disease is supported by the growth spurt reported with parenteral supplementation. 34 The lack of a genotype difference in iron status appears inconsistent with a role of early suboptimal nutrition. Serum iron and transferrin saturation are relatively insensitive indices of iron status as they are influenced by erythropoietic activity in the short term and earlier observations in the cohort study revealed higher serum iron in SS disease at ages [1] [2] [3] [4] years.35 Serum ferritin might have given a better indicator of iron status but values in early childhood were not available in the cohort study. The lack of access to magnetic resonance imaging has not allowed correlation of the IQ findings to 'subclinical' abnormalities of brain structure, and we cannot exclude such changes as a cause of the lowered IQ. However, if these changes were vaso-occlusive in origin, they might be expected to be more frequent in patients with low fetal haemoglobin concentrations and the lack of a relationship of fetal haemoglobin and IQ is against this.
A modest but statistically significant reduction in IQ has occurred in SS disease in the present study and is not attributable to commonly assumed factors such as school absenteeism or disease severity. We are aware of the disquieting nature of these observations but the relationship of lowered IQ with reduced growth in height suggests a potentially correctable mechanism and urges that future studies be focused on early nutrition.
